Elanco Animal Health Inc.
Income Statement
| Line Item | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 |
|---|---|---|---|---|---|---|---|---|
| Revenue | $4.72B | $4.44B | $4.42B | $4.41B | $4.76B | $3.27B | $3.07B | $3.07B |
| Cost of Revenue | $2.12B | $2.00B | $1.93B | $1.91B | $2.13B | $1.67B | $1.47B | $1.57B |
| Gross Profit | $2.59B | $2.44B | $2.49B | $2.50B | $2.63B | $1.61B | $1.60B | $1.49B |
| Gross Margin | 55.0% | 54.9% | 56.3% | 56.6% | 55.2% | 49.1% | 52.1% | 48.7% |
| Operating Expenses | ||||||||
| Research & Development | $368.0M | $344.0M | $327.0M | $321.0M | $369.0M | $329.0M | $270.0M | $246.6M |
| SG&A Expense | $1.43B | $1.31B | $1.29B | $1.27B | $1.40B | $997.0M | $760.0M | $735.2M |
| Operating Income | $-224.0M | $488.0M | $-918.0M | $169.0M | $-335.0M | $-527.0M | $157.0M | $143.7M |
| Operating Margin | -4.8% | 11.0% | -20.8% | 3.8% | -7.0% | -16.1% | 5.1% | 4.7% |
| Interest Expense | — | — | $277.0M | $241.0M | $236.0M | $150.0M | $79.0M | $29.6M |
| Pretax Income | $-224.0M | $488.0M | $-1.20B | $-72.0M | $-571.0M | $-677.0M | $78.0M | $114.1M |
| Income Tax Expense | $8.0M | $150.0M | $36.0M | $6.0M | $-88.0M | $-103.0M | $10.0M | $27.6M |
| Net Income | $-232.0M | $338.0M | $-1.23B | $-78.0M | $-483.0M | $-574.0M | $68.0M | $86.5M |
| Net Margin | -4.9% | 7.6% | -27.9% | -1.8% | -10.1% | -17.5% | 2.2% | 2.8% |
| EPS (Basic) | $-0.47 | $0.68 | $-2.50 | $-0.16 | $-0.99 | $-1.30 | $0.18 | $0.28 |
| EPS (Diluted) | $-0.47 | $0.68 | $-2.50 | $-0.16 | $-0.99 | $-1.30 | $0.18 | $0.28 |
| Shares Outstanding (Basic) | 496.4M | 494.0M | 492.3M | 488.3M | 487.2M | 441.4M | 369.0M | 313.7M |
| Shares Outstanding (Diluted) | 496.4M | 497.3M | 492.3M | 488.3M | 487.2M | 441.4M | 370.3M | 313.7M |
| Dividends Per Share | — | — | — | — | — | — | — | — |